OnKure Therapeutics, Inc. (OKUR)
2.37
-0.16
(-6.14%)
USD |
NASDAQ |
Nov 06, 10:21
OnKure Therapeutics Net Income (Quarterly) : -17.85M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -17.85M |
| June 30, 2026 | -15.35M |
| March 31, 2026 | -15.16M |
| December 31, 2025 | -13.50M |
| September 30, 2025 | -14.70M |
| June 30, 2025 | -15.39M |
| March 31, 2025 | -15.92M |
| December 31, 2024 | -35.19M |
| September 30, 2024 | -11.56M |
| June 30, 2024 | -14.14M |
| March 31, 2024 | -9.536M |
| December 31, 2023 | -9.455M |
| September 30, 2023 | -19.20M |
| June 30, 2023 | -19.53M |
| Date | Value |
|---|---|
| March 31, 2023 | -15.11M |
| December 31, 2022 | -13.60M |
| September 30, 2022 | -13.01M |
| June 30, 2022 | -12.31M |
| March 31, 2022 | -13.04M |
| December 31, 2021 | -10.61M |
| September 30, 2021 | -12.74M |
| June 30, 2021 | -9.216M |
| March 31, 2021 | -7.212M |
| December 31, 2020 | -6.253M |
| September 30, 2020 | -5.094M |
| June 30, 2020 | -3.687M |
| March 31, 2020 | -4.431M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Heron Therapeutics, Inc. | -5.489M |
| Tonix Pharmaceuticals Holding Corp. | -40.55M |
| Karyopharm Therapeutics, Inc. | -67.02M |
| Minerva Neurosciences, Inc. | 17.47M |
| Corbus Pharmaceuticals Holdings, Inc. | -35.04M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 17.85M |
| EPS Diluted (Quarterly) | -0.3574 |
| Enterprise Value | -60.24M |
| Earnings Yield | -116.7% |
| Normalized Earnings Yield | -116.73 |